eravacycline dihydrochloride

eravacycline dihydrochloride (XERAVA) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

XERAVA is a marketed brand name for eravacycline dihydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

eravacycline dihydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.